dysarthria, and respiratory impairment, necessitating hospitalization and mechanical ventilation. Physical examination confirmed multiple cranial nerve abnormalities, including extraocular motor palsy and diffuse flaccid paralysis. Possible botulism was diagnosed, and a one-vial dose of trivalent (types A, B, and E) antibotulinum toxin was administered. A sample of the patient's serum collected before antitoxin administration demonstrated the presence of type B botulinum toxin. A food history revealed no exposures to home-canned products; however, the patient had eaten pickled eggs that he had prepared 7 days before onset of illness; gastrointestinal symptoms began 12 hours after ingestion. The patient recovered after prolonged supportive care.
The pickled eggs were prepared using a recipe that consisted of hard-boiled eggs, commercially prepared beets and hot peppers, and vinegar. The intact hard-boiled eggs were peeled and punctured with toothpicks then combined with the other ingredients in a glass jar that closed with a metal screw-on lid. The mixture was stored at room temperature and occasionally was exposed to sunlight.
Cultures revealed Clostridium botulinum type B, and type B toxin was detected in samples of the pickled egg mixture at CDC's National Botulism Surveillance and Reference Laboratory. C. botulinum was cultured from the pickling liquid, beets, and egg yolk. The concentration of preformed type B toxin was 1000 times greater in the egg yolks than in the pickling liquid and was undetected in the beets. Peppers from the original commercial container contained no detectable toxin, and bacterial cultures of the peppers did not yield C. botulinum. Beets from the original commercial containers were not available. The pH of the pickling liquid was 3.5 (i.e., adequate to prevent C. botulinum germination and toxin formation. However, the pH of the egg yolk was not determined [normal egg yolk pH: 6.8]). Editorial Note: Botulism is a paralytic illness caused by the neurotoxin produced by the bacterium C. botulinum. Paralysis first affects the cranial nerves, then the skeletal muscles; untreated intoxications can lead to dense flaccid paralysis, respiratory failure, and death (1, 2 ) .
Although rare and sporadic, foodborne botulism is a persistent cause of morbidity and mortality in the United States. In 1997, an annual survey of state epidemiologists and directors of state public health laboratories identified 24 cases of foodborne botulism with one associated death (CDC, unpublished data, 1998). During 1989-1998, a median of 23 cases (range: 17-42 cases) of foodborne botulism was reported each year with a median of one death (range: 0-2 deaths).
C. botulinum spores are ubiquitous. Safe food preservation methods destroy spores or inhibit their germination and growth. Conditions that promote germination and growth of C. botulinum spores include absence of oxygen (anaerobic conditions), low acidity (pH >4.6), temperatures >39 F [4 C]), and high moisture content. Most foodborne botulism cases that occur in the United States are the result of improperly home-canned foods. This is the first reported case of botulism related to eating pickled eggs. The amount of toxin detected in the recovered egg yolk suggested that bacterial growth was concentrated in that portion of the egg. Intact eggs that have been hard-boiled should be free of bacteria or spores. Pricking cooked eggs may introduce C. botulinum spores into the
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Foodborne Botulism -Continued yolk. Portions of the yolk that remained anaerobic and inadequately pickled (i.e., not acidified to pH £4.6) may have allowed C. botulinum spores to germinate, grow, and form toxin. Setting the pickling jar in sunlight provided warmth that facilitated bacterial growth and toxin production.
To reduce the risk for botulism when pickling, food items should be washed and cooked adequately, and utensils, containers, and other surfaces in contact with food, including cutting boards and hands, should be cleaned thoroughly with soap and warm water. Containers (e.g., jars and lids) in which pickling will occur should be sterilized (e.g., placed in boiling water for the prescribed period published in the container instructions) (3 ) . Adequate acidification to a pH £4.6 is essential. Refrigeration at 39 F (4 C) during pickling is advisable, especially in foods that may be acidified inadequately such as whole eggs. Once opened, any canned or pickled food should be refrigerated. Pricking, poking holes, or otherwise handling whole eggs in a manner that might allow spores or bacteria into the yolk should be avoided.
When foodborne botulism is suspected, clinicians and public health investigators should inquire about the preparation and eating of foods preserved by any home method (e.g., canning, pickling, curing, and fermenting). Persons seeking advice on home-food preservation should consult their local county or university cooperative extension service, or contact the U.S. Department of Agriculture Food Safety Hotline, telephone (800) 535-4555. CDC provides epidemiologic consultation and laboratory diagnostic services for suspected botulism cases and authorizes release of botulism antitoxin. Through state health departments, these services are available 24 hours a day from CDC.
The recall was issued following customer complaints and subsequent investigations by the manufacturer that found that vials of streptomycin may have been labeled inadvertently as the recalled lot of INH. A second lot of INH (drug lot no. 0077261) that was implicated initially is no longer involved in the recall. In the original complaint involving lot no. 0077261, the incorrect lot number was reported to the manufacturer. This recall does not affect other sources of INH used for AST or for therapeutic purposes.
Laboratories Clinicians and patients using the standard 6-month four-drug regimen for tuberculosis (1 ) should be reassured because 1) in the United States, most patients are treated successfully with this regimen; 2) most patients are infected with strains of M. tuberculosis that are susceptible to all first-line antituberculosis drugs (2 ); and 3) results from controlled clinical trials indicate that this regimen is effective for patients infected with INH monoresistant M. tuberculosis (3 ) . Therefore, patients who have completed this regimen and who have been discharged as cured before repeat AST results are available do not need additional drug therapy even if INH resistance is subsequently identified. Patients found to have INH monoresistant organisms after induction therapy is complete (e.g., during continuation phase of therapy with INH and rifampin) should be evaluated for treatment failure clinically and with cultures. Patients with an acceptable clinical course and no evidence of treatment failure could complete the continuation phase with INH and rifampin. In both instances, patients should be screened clinically for recurrent tuberculosis at 3, 6, and 12 months after completion of therapy and, if relapse is suspected, cultures should be obtained.
Patients who are identified as infected with INH monoresistant organisms before the induction phase of therapy is completed may be treated with a combination of rifampin, pyrazinamide, and ethambutol (or streptomycin) for 6 months. INH also may be included if repeat AST is resistant to INH at low levels (e.g., 0.1 µg/mL BACTEC™ media, or 0.2 µg/mL 7H10 media) but is not resistant at high levels (e.g., 0.4 µg/mL BACTEC™ media, or 1 µg/mL 7H10 media). Antituberculosis therapy and monitoring should be individualized for patients treated with other regimens, for patients who have not responded to therapy as expected, or for patients infected with M. tuberculosis strains resistant to one or more drugs in addition to INH. Patients with unrecognized INH monoresistance who were treated with the two-drug regimen of INH and rifampin and those treated initially with INH, rifampin, and pyrazinamide are at increased risk for treatment failure and/or relapse after treatment, possibly associated with acquired rifampin resistance. If a change in the treatment regimen is considered necessary, the initial regimen should be augmented with at least two additional drugs to which the patient's M. tuberculosis isolate has been proven susceptible and, if possible, which the patient has not received previously.
Notice to Readers

Drive Safely Work Week -September 11-15, 2000
The Network of Employers for Traffic Safety (NETS), a nonprofit organization comprising corporate, state, and federal partners, is sponsoring the fourth annual Drive Safely Work Week during September 11-15, 2000. Unintentional injuries are the leading cause of death in the United States for persons aged 1-44 years and accounted for approximately 97,000 deaths among persons of all ages in 1997 (1 ). In 1998, approximately 41,000 persons died on U.S. highways and another 3.2 million suffered nonfatal injuries (2 ) .
Highway fatalities have decreased substantially since 1966 (n=50,984), and the fatality rate per mile of travel has decreased more than threefold (from 5.5 in 1966 to 1.6 in 1998) (3 ). However, minimal changes have occurred in the numbers of fatalities and the fatality rate per mile from 1994 to 1998. Although most injuries and fatalities in 1998 were to vehicle occupants, pedestrians accounted for 5220 of the fatalities and 69,000 of the injuries (4 ). Motor-vehicle crashes also are the leading cause of occupational injury deaths, accounting for approximately 16,000 deaths in workers from 1980 to 1992, or 20% of all fatal workplace injuries over this period (5 ) .
The national campaign to prevent motor-vehicle crashes includes a "toolkit" that contains information, posters, and suggested programs that employers or other groups can use to address five major traffic safety issues: safety belt use, aggressive driving, driver inattention, sharing the road with trucks, and impaired driving. The materials are not dated and may be used throughout the year.
Additional information about NETS and purchasing the toolkit (cost: $25) is available on the World-Wide Web, http://www.trafficsafety.org,* or telephone, (202) 114  134  159  244  2,573  2,532  416  2,363  Alaska  -1  21  7  38  34  23  18  Hawaii  3  11  --139  259  144 207
N: Not notifiable. U: Unavailable.
-: No reported cases. * Individual cases can be reported through both the National Electronic Telecommunications System for Surveillance (NETSS) and the Public Health Laboratory Information System (PHLIS). 
U: Unavailable.
-: No reported cases. *Individual cases can be reported through both the National Electronic Telecommunications System for Surveillance (NETSS) and the Public Health Laboratory Information System (PHLIS). 
